News
There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...
Receiving a COVID-19 booster vaccine in the same arm as the first vaccine dose leads to a faster, more effective immune ...
A new randomized study could cost Novavax tens of millions of dollars, vaccine experts say ...
A Cleveland Clinic web page describing myocarditis survival rates was misrepresented online as news that millions who received COVID-19 vaccines were about to die.
Novavax said on Wednesday U.S. regulators asked the company to produce more data on its COVID-19 vaccine if it gets full ...
Trinity College Dublin researchers have found that the BNT162b2 COVID-19 vaccine may offer protection beyond its intended ...
CHICAGO (Reuters) -Thousands of Americans campaigning for the Novavax COVID-19 booster got some good news this week: the FDA ...
Vaccines for the flu and COVID-19 can alter the menstrual cycle, but the impact is temporary and there is no reason for vaccine hesitancy, while breast cancer deaths among women ages 20 to 49 ...
When COVID-19 first emerged, the U.S., under President Donald Trump, made an urgent bet on vaccines — and it paid off ...
2don MSN
The FDA has discussed with vaccine-maker Novavax the need for an additional trial of its COVID-19 vaccine as a post-approval ...
The vaccine is the only protein-based COVID shot still in use in the U.S. This approval would allow the vaccine to stay on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results